SeroVital-hgh
Allegations: Falsely marketing that supplements increase human growth hormone (HGH) levels by 682%, make users look decades younger, and provide various anti-aging benefits
In Oct 2016, a class-action lawsuit was filed against Sanmedica International for allegedly falsely advertising that Sero Vital-hgh provides anti-aging benefits. Specifically, the complaint alleges that the company markets the pill as, among other things, having the ability to “turn back time” in the human aging process and increase Human Growth Hormone (HGH) levels in the body by 682% when, in reality, such claims are false. (Martin et al v. Sanmedica International, LLC and Does 1-10, Case No. 16-cv-7794, C. D. CA.)
For more information about other class-action lawsuits regarding anti-aging products and TINA.org’s coverage of them, click here.
Allegations: Falsely marketing that supplements increase human growth hormone (HGH) levels by 682%, make users look decades younger, and provide various anti-aging benefits
Allegations: Falsely advertising that products increase HGH levels and provide health and anti-aging benefits
April 2017: The Ninth Circuit Court of Appeals affirmed the district court’s decision to dismiss this lawsuit. March 2015: The plaintiffs appealed the district court’s decision to dismiss the lawsuit.…
Verdict comes nine years after TINA.org alerted regulator to supplement’s unsubstantiated health claims.
Regulators have a beef with company’s climate pledge.
Consumers need to be wary of undisclosed incentivized reviews.
Why TINA.org supports FTC’s proposed changes to COPPA Rule but pushes for more.
FTC alleges company pressures consumers into overpaying for its tax filing software.